Cepheid, Sample Collection Device, Part: 900-0370
FDA Device Recall #Z-2584-2024 — Class II — June 20, 2024
Recall Summary
| Recall Number | Z-2584-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 20, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Cepheid |
| Location | Sunnyvale, CA |
| Product Type | Devices |
| Quantity | 651,150 |
Product Description
Cepheid, Sample Collection Device, Part: 900-0370
Reason for Recall
Specimen collection device may leak after the patient sample swabs have been inserted into the test tubes, which could result in biohazard exposure, cross contamination causing false positive results for other specimens, and/or delay to test results.
Distribution Pattern
Worldwide distribution: US (nationwide): IL, TX, OH, LA, NY, CA, MD, IA, MN, KY, NH, WI, MO, NC, UT, WA, FL, NJ, SC, CO, PA, SD, NE, MT, WV, GA, MA, RI, CT, DE, MS, OK, VA, ID, AZ, OR, MI, IN, TN, AL, KS, ME, AR, NV, HI, AK, NM, WY, VT, ND, DC OUS (foreign) to countries of: Chile, Ireland, Oman, Nicaragua, Germany, San Marino, Ecuador, New Caledonia, France, Austria, United Kingdom, Finland, Italy, Hong Kong, Kuwait, United Arab Emirates, Netherlands, Belgium, Monaco, Colombia, Spain, Portugal, Poland, Switzerland, Denmark, Jersey, Mexico
Lot / Code Information
UDI-DI: 28053326001523. Lot/Expiration: 230397900/ July 3, 2024; 230535300/ July 14, 2024; 230627500/ August 4, 2024; 231877400/ April 10, 2025
Other Recalls from Cepheid
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0724-2026 | Class II | Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10. | Nov 5, 2025 |
| Z-0960-2026 | Class II | Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... | Oct 30, 2025 |
| Z-0959-2026 | Class II | Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog... | Oct 30, 2025 |
| Z-0414-2026 | Class II | Xpert SA Nasal Complete Catalog Number: GXSACO... | Aug 6, 2025 |
| Z-0216-2024 | Class II | Xpert Xpress Strep A, REF:Xprstrepa-CE-10, CE IVD, | Apr 24, 2023 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.